IRF2BPL

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, IRF2BPL mutation is significantly associated with the RNA expression of many other genes, with 2,910 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible IRF2BPL-associated genes across cancer lineages are RNA5SP420, FCGBP, and C17orf98. Each is linked with IRF2BPL in more than 2 cancer types. Because this analysis shows association rather than direction, both IRF2BPL-to-partner and partner-to-IRF2BPL results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, RNA5SP420 grouped by IRF2BPL-low versus IRF2BPL-high in LUSC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (IRF2BPL→partner) and Y-score (partner→IRF2BPL) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUSCRNA5SP420 →+0.631+4.309<.001.00733
UCECFCGBP →-1.215-3.791<.001<.00132
UCECC17orf98 →+0.479+2.782<.001<.00132
LUSCRNU6-1092P →+0.557+5.211<.001<.00132
ESCATSPY24P →+0.076+5.068<.001.00832
CESCGYG2P1 →+0.022+4.601.003.00432
Each partner links to its Q-omics profile. Showing the 6 strongest of 2,910 associations by consensus.

RNA5SP420 by IRF2BPL expression — LUSC

Box plot of RNA5SP420 in IRF2BPL-low vs IRF2BPL-high samples in LUSC.

Explore this box plot interactively →

Exploration